Peptonic Medical
Peptonic Medical signs global agreement with Siemens Healthineers
The agreement with Siemens Healthineers is global and non-exclusive. It centers around Peptonic's patented diagnostic products for vaginal health.
"This agreement is attractive from many aspects. We will get a very strong force in Siemens Healthineers that will help to raise awareness of the benefits of our unique and patented technology," said Erik Sundquist, CEO of Peptonic Medical.
The agreement with Siemens Healthineers is expected to contribute positively to Peptonic's revenues from 2024.
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care.
This disclosure contains information that PEPTONIC Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 20-04-2023 08:34 CET.
| Datum | 2023-04-20, kl 08:34 |
| Källa | Cision |
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.